Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Triple Flag Declares Q4 2026 Dividend of US$0.06
-
Mineros to Hold Conference Call for Q3 2026 November 12, 2026
-
D-BOX to Announce Second Quarter 2027 Financial Results
-
BOARDWALK REIT REPORTS Q3 2026 RESULTS
-
VitalHub Announces Q3 2026 Conference Call Date
-
Swiss Water Reports Continued Momentum with Third Quarter 2026 Results
-
American Financial Group, Inc. Announces Third Quarter Results and Declares Special Dividend
-
Gates Industrial to Participate in the Baird 2026 Global Industrial Conference
-
WEIS MARKETS REPORTS THIRD QUARTER 2026 RESULTS
-
3M Board Approves New $6 Billion Share Repurchase Authorization, Declares Quarterly Dividend
-
Badger Meter Acquires 37South, Further Expanding Global Operations to Australia
-
MasterCraft & RealTruck’s Custom Truck-and-Boat Build to Be Auctioned for Charity During Barrett-Jackson’s 2027 Scottsdale Auction
-
Kodiak AI Delivers Western Star 49X Trucks to Atlas Energy Solutions, Beginning Next Autonomous Chapter in the Permian Basin
-
Ferroglobe Reports Third Quarter 2026 Financial Results and Announces Actions to Improve Profitability
-
BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) Announces Distribution
-
UFP Technologies Announces Strong Q3 Results
-
Avenzo Therapeutics to Participate at Upcoming Investor Conferences
-
Can Neuroscience Help Explain Spiritual Experience?
-
Telos Corporation Awarded Xacta Contract by U.S. Department of State
-
Ocular Hypertension Market is Expected to Witness Growth by 2034 Owing to the Rising Prevalence of Elevated Intraocular Pressure and Growing Focus on Glaucoma Prevention | DelveInsight
-
Bulimia Nervosa Market is Projected to Witness Significant Growth by 2036 Owing to Rising Disease Awareness and Increasing Demand for Effective Treatment Approaches | DelveInsight
-
Acute Myocardial Infarction Market Size in the 7MM is projected to grow at a 13% CAGR over the forecast period of 2026-2036 | DelveInsight
-
Caesarstone Reschedules Third Quarter 2026 Results and Conference Call to November 11, 2026
-
BerryDunn Awarded Texas DIR DBITS Contract for Technology Consulting Services
-
Trans Canada Gold Advances Phase 2-Drilling at the Harrison Lake District Scale Gold Project and Awaits PhotonAssay Results From Phase 1-Drilling
-
Heart Failure Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Abbott, Berlin Heart GmbH, Biotronik, Boston Scientific Corp, Jarvik Heart Inc
-
22q11.2 Deletion Syndrome Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2026-2036 | DelveInsight
-
Frontotemporal Dementia Market Size in the 7MM is projected to grow at a ~15% CAGR over the forecast period of 2026-2036 | DelveInsight
-
Hypercholesterolemia Market Projected to Achieve Substantial Growth by 2036, Led by Key Companies and Strategic Developments | Novartis, Esperion Therapeutics, Esperion Therapeutics, EPIC BIO, Amytrx
-
Metastatic HR+/HER2− Breast Cancer Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2026-2036 | DelveInsight
-
Concentrix Announces Chief Financial Officer Succession
-
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Innospec REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
-
First Industrial Declares Common Stock Dividends
-
60 Seconds to Sellout: How Maureen Kelly Built tarte's Fastest-Selling Collab alongside Roller Rabbit
-
TVS Breaks New Ground at EICMA 2026 With Everyday Urban Sportsbike RTR 125 LC
-
Western Forest Products and Tla’amin Nation Complete Sale of Stillwater Forest Operation
-
ReeXploration Announces Effective Date of Five-for-One Share Consolidation
-
ILC Dover Agrees to Pay Record High $13 Million to Settle Cybersecurity False Claims Act Case Brought by Whistleblower Law Collaborative Client
-
MediWound Announces $15 Million Bought Deal Offering of Ordinary Shares
-
Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing Investments and Innovation | AstraZeneca, Daiichi Sankyo, Bristol-Myers Squibb, Amgen, Jazz Pharma, BeiGene, Zymeworks, ALX Oncology
-
Cutaneous Lupus Erythematosus Pipeline Analysis 2026: Phase III and Phase II Assets, MOA Breakdown, and ROA Trends | Biogen, Horizon Therapeutics, Bristol–Myers Squibb, AstraZeneca, Sanofi, Amgen
-
Mantle Cell Lymphoma Clinical Trial Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
-
What’s Fueling the Ovarian Cancer Market Boom? Industry to Cross USD 5.7 Billion by 2034 | pharma& GmbH, GlaxoSmithKline, Verastem Oncology, Daiichi Sankyo, AstraZeneca, ProfoundBio, Genmab, Tesaro
-
One World Chain Launches EVM-Compatible Layer 1 Blockchain and Activates Native OWCT Asset
-
Kadant Reports Third Quarter 2026 Results
-
MotorWeek announces streaming deal with DRIVEN
-
Glucagon-Like Peptide Agonist Clinical Trial Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
-
AM Best Revises Outlooks to Positive for Funeral Directors Life Insurance Company
-
JELD-WEN Reports Third Quarter 2026 Results


